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levels. 30.6% of patients had high aFXa levels, 
including 12.2% of the population who were ther-
apeutically anti-coagulated. Patient weight pre-
dicted enoxaparin metabolism (r2value of 0.45). 
When compared to patients given enoxaparin 
40mg once daily, patients given enoxaparin 40mg 
twice daily 1) were significantly less likely to have 
low aFXa (9.2% vs. 44.1%, p<0.001), 2) had non-
significant increase in clinically relevant bleeding 
(6.1% vs. 3.2%%, p=0.34), and 3) had significantly 
fewer post-operative VTE (0% vs. 5.3% p=0.021).
CONCLUSION: With enoxaparin 40mg twice 
daily, only 9.2% of patients receive inadequate 
prophylaxis based on aFXa level. This is relevant 
because prior work has correlated inadequate 
prophylaxis with symptomatic VTE after plastic 
surgery procedures. When compared to patients 
who receive enoxaparin 40mg per day, patients 
who receive enoxaparin 40mg twice daily had 
significantly fewer VTE and had non-significant 
increase in clinically relevant bleeding. Ongoing 
patient recruitment will further define the effec-
tiveness and safety profile of this intervention.
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INTRODUCTION: In children, esophageal defects 
cause significant morbidity. The Foker procedure, 
gastric pull-up, and colonic interposition have 
demonstrated success in establishing esophageal 
continuity. However, these forms of esophageal 
repair are susceptible to failure. Additionally, cases 
exist where varied anatomy and previous surgery 
may preclude the application of these procedures. 
In such cases, jejunal interposition may be consid-
ered. “Supercharging” pedicled jejunal flaps allows 
for longer conduits, and serves to improve flap per-
fusion, healing, and function. Previous studies have 
questioned the feasibility of this intervention in a 
pediatric population. The purpose of this study is 
to describe the outcomes of pediatric patients who 
underwent supercharged jejunal interposition for 
esophageal reconstruction at our institution.
METHODS: We reviewed the records of patients 
who underwent esophageal reconstruction using 
supercharged pedicled jejunal (SPJ) flaps at our 
institution from 2013–2017.
RESULTS: Thirteen patients, aged 1.4–23.8 years, 
underwent esophageal reconstruction with SPJ 
flaps. Eleven patients had esophageal atresia and 
two developed esophageal strictures secondary to 
caustic ingestion. All had previously undergone 
failed attempts at restoring esophageal continu-
ity. Patients have been followed-up for an average 
of 19.7 months. Reconstruction with SPJ flaps was 
laborious and technically demanding, taking an 
average of 11.8 ± 3.1 hours. Most cases (92.3%) 
involved the microsurgical anastomoses of an 
internal thoracic artery and vein to jejunal arte-
rial and venous branches, respectively. All patients 
were discharged with an intact SPJ flap, and there 
were no morbidities. For two children, the postop-
erative course was complicated by chest wall infec-
tions; another individual experienced small bowel 
obstruction. So far, four patients have required 
endoscopic stricture dilation, and one child has 
returned to the operating room for relocation of 
their jejunogastric anastomosis. Following recon-
struction, patients were intubated for an average 
of 8.7 ± 3.7 days, and monitored in the intensive 
care unit for a mean of 18.0 ± 7.3 days. By postop-
erative day 50 (range, 15–50 days), all were able 
to meet their caloric needs enterally. Currently, 
eleven patients (84.6%) are tolerating oral feeds.
CONCLUSION: Although the complexity of 
SPJ flaps limits their widespread use, our group’s 
experience with this technique demonstrates the 
feasibility of this intervention in the pediatric 
population. When performed by an experienced, 
multidisciplinary team, this approach is reliable 
and should be considered for children with lim-
ited reconstructive options.
